An IVF Alternative Could Make Having Babies Less Onerous
New York startup Gameto is revolutionising the in vitro fertilisation (IVF) process with a technique that matures eggs outside the body, potentially reducing the reliance on hormone treatments and making the path to pregnancy less burdensome.
Key Points
- Gameto’s new method replaces up to 80% of hormone injections traditionally required for IVF, shortening treatment cycles to just a few days.
- The technique has shown promising results, including higher embryo viability and pregnancy rates compared to conventional in vitro maturation (IVM).
- Fertilo, Gameto’s product, uses ovarian support cells derived from stem cells for incubating extracted eggs.
- A recent study reported a 44% pregnancy rate following the Fertilo method, compared to 20% with standard IVM.
- The approach may significantly reduce costs and discomfort associated with traditional IVF, potentially opening access to more patients.
Content Summary
The traditional IVF process involves lengthy hormone treatments that can cause discomfort and financial strain on patients hoping to conceive. Gameto has developed a method known as Fertilo, which matures eggs using ovarian support cells outside the body. This alternative drastically reduces the need for hormone injections, shortening the overall treatment time and significantly lowering the physical and financial burden of the IVF process.
Initial results from trials indicate that Fertilo leads to a higher success rate in terms of embryo viability compared to traditional methods. The study involved 40 patients and showed promising outcomes, including multiple ongoing pregnancies. With the potential for approval in various countries and a large clinical trial underway in the US, Gameto is aiming to position Fertilo as a viable option for patients seeking less invasive and more financially accessible fertility treatments.
Why should I read this?
This article highlights a groundbreaking development in fertility treatment that could reshape the IVF landscape. Gameto’s innovative approach may provide hope for individuals and couples struggling with traditional IVF’s high costs and physical demands, especially those with conditions like polycystic ovarian syndrome (PCOS). By understanding these advancements, readers can stay informed about options that may better suit their reproductive health needs.
“`